HUM vs NRIX
Humana Inc (HUM) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the HUM and NRIX stock pages for the full models.
Not investment advice.